Patents by Inventor Richard Gedrich

Richard Gedrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS
    Publication number: 20180311220
    Abstract: The present invention provides compositions and methods for treating cancers which have acquired resistance to a KIT inhibitor by administering effective amounts of DAST.
    Type: Application
    Filed: July 10, 2018
    Publication date: November 1, 2018
    Applicant: Bayer HealthCare LLC
    Inventors: Scott Wilhelm, Richard Gedrich
  • TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS
    Publication number: 20170165242
    Abstract: The present invention provides compositions and methods for treating cancers which have acquired resistance to a KIT inhibitor by administering effective amounts of DAST.
    Type: Application
    Filed: January 24, 2017
    Publication date: June 15, 2017
    Applicant: Bayer HealthCare LLC
    Inventors: Scott WILHELM, Richard GEDRICH
  • TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS
    Publication number: 20150018393
    Abstract: The present invention provides compositions and methods for treating cancers which have acquired resistance to a KIT inhibitor by administering effective amounts of DAST.
    Type: Application
    Filed: March 5, 2014
    Publication date: January 15, 2015
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Scott WILHELM, Richard GEDRICH
  • UREA COMPOUNDS USEFUL IN THE TREATMENT OF CANCER
    Publication number: 20110195110
    Abstract: Pyrazole urea compounds, pharmaceutical compositions which contain them and methods for treating cancer using them.
    Type: Application
    Filed: December 1, 2006
    Publication date: August 11, 2011
    Inventors: Roger Smith, Holia N. Hatoum-Mokdad, Louis David Cantin, Donald E. Bierer, Wenlang Fu, Dhanapalan Nagarathnam, Gaetan Ladouceur, Yamin Wang, Herbert Ogutu, Scot Wilhelm, Ian Taylor, Sanjeeva Reddy, Richard Gedrich, Christopher Carter, Aaron Schmitt, Xiaomei Zhang
  • Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192
    Publication number: 20060078498
    Abstract: The present invention relates to methods for the identification and characterization of polypeptides with ligand activity for the G protein coupled receptor (GPCR) 192. The invention encompasses the use of the ligands in combination with the receptor for the development of assays/kits for the identification of molecules that affect the ability of the ligand to interact with the receptor. In addition, the invention relates to molecules affecting the expression of the ligands (e.g., antisense DNA, ribozymes, antibodies) that may modulate the activity of the receptor. The invention also encompasses the use of the ligands and their derivatives, molecules affecting ligand expression, and compounds that modulate receptor activity for the treatment of disorders involving GPCR 192, such as those of the central nervous system, metabolic disorders (e.g., pancreatic disorders), gastrointestinal disorders, immune disorders, and cancer.
    Type: Application
    Filed: March 28, 2003
    Publication date: April 13, 2006
    Applicant: Bayer Pharmaceuticals Corporatioh
    Inventors: Thomas Buckholz, Mark Vandenberg, Carla Prllrgrino, Stefan Heitmeier, Ian Taylor, Richard Gedrich